Alyson Shontell sits down with Johnson & Johnson CEO Joaquin Duato to discuss how AI is being used in cancer cell therapy to attack the cells and turn the cancer into a chronic illness. The company's also using robotics technology to assist surgeons to significantly improve the average outcome of the surgeries.